Medicare Enrolled
Dr. Robert Sangrigoli, MD
Cardiovascular Disease · Doylestown, PA
Practice pattern: Electrophysiology & Remote
— Practice combining electrophysiology and remote services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sangrigoli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sangrigoli?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sangrigoli
Dr. Robert Sangrigoli is a cardiovascular disease specialist in Doylestown, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sangrigoli performed 2,545 Medicare services across 1,983 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sangrigoli received a total of $35,236 from 21 pharmaceutical and/or device companies across 150 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sangrigoli is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 30% volume in PA
$35,236 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,545
Medicare services
Top 30% in PA for cardiovascular disease
1,983
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~127 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
663 | $6 | $30 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
425 | $11 | $80 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
212 | $141 | $290 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
177 | $98 | $205 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
144 | $16 | $90 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
122 | $54 | $455 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
83 | $21 | $100 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
80 | $97 | $200 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
78 | $65 | $150 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
61 | $24 | $210 |
| Atrial fibrillation ablation with pulmonary vein isolation A procedure to treat atrial fibrillation by mapping the heart's electrical activity and destroying tissue causing irregular contractions. This is done by isolating the pulmonary veins using catheter-based destruction. |
54 | $780 | $3,650 |
| New patient office visit, complex (60-74 min) | 52 | $170 | $355 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
51 | $18 | $80 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
51 | $27 | $75 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
48 | $9 | $42 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
48 | $16 | $65 |
| Heart chamber tissue destruction via catheter A procedure that destroys tissue in the upper heart chamber using a tube to treat abnormal heart rhythm. |
37 | $254 | $1,370 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
30 | $137 | $300 |
| Insertion of implantable heart rhythm monitor A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit. |
20 | $72 | $450 |
| Pacemaker insertion with heart chamber electrodes A surgical procedure to implant a pacemaker device and place electrodes into the upper and lower chambers of the heart to regulate heart rhythm. |
19 | $419 | $1,775 |
| Catheter ablation for abnormal heart rhythm A procedure where catheters are inserted to destroy tissue causing irregular heartbeats. |
18 | $254 | $1,365 |
| Insertion of implantable defibrillator system A surgical procedure to place an implantable cardioverter-defibrillator (ICD) device into the body. The device is connected to the heart to monitor heart rhythm and deliver shocks if dangerous arrhythmias occur. |
16 | $747 | $3,060 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
16 | $67 | $190 |
| Insertion of left lower heart electrode for pacemaker or defibrillator A procedure to place an electrode in the lower part of the left side of the heart. This electrode is used to connect a pacemaker or defibrillator to help regulate the heart's rhythm. |
14 | $384 | $1,545 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
13 | $20 | $65 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $99 | $275 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
22.9% high complexity
0.0% medium
77.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$35,236
Total received (2018-2024)
Avg $5,034/year across 7 years
Top 11% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
150
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$29,617 (84.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,545 (12.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,074 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,195
2023
$342
2022
$407
2021
$1,232
2020
$861
2019
$8,630
2018
$21,570
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$2,040
Novartis Pharmaceuticals Corporation
$44
Boston Scientific Corporation
$42
E.R. Squibb & Sons, L.L.C.
$31
Actelion Pharmaceuticals US, Inc.
$23
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$14
Top 3 companies account for 96.9% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic Vascular, Inc.
$26,391
Janssen Pharmaceuticals, Inc
$4,032
Medtronic, Inc.
$3,406
Abbott Laboratories
$263
Novartis Pharmaceuticals Corporation
$229
E.R. Squibb & Sons, L.L.C.
$207
Boston Scientific Corporation
$157
PFIZER INC.
$112
Actelion Pharmaceuticals US, Inc.
$76
AstraZeneca Pharmaceuticals LP
$72
SANOFI-AVENTIS U.S. LLC
$71
Biosense Webster, Inc.
$47
Regeneron Healthcare Solutions, Inc.
$29
iRhythm Technologies, Inc.
$24
Philips Electronics North America Corporation
$23
NOVARTIS PHARMACEUTICALS CORPORATION
$21
Merck Sharp & Dohme Corporation
$17
CARDIVA MEDICAL, INC.
$17
Amgen Inc.
$14
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$14
Gilead Sciences, Inc.
$12
Top 3 companies account for 96.0% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · AZURE XT DR MRI SURESCAN · Arctic Front · BRILINTA · CAMZYOS · CARTO 3 · CHANTIX · COBALT DR MRI SURESCAN · CONFIRM RX · Cardiac Mapping System · CareLink Express · Corlanor · DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER · ELIQUIS · ENSITE PRECISION · ENTRESTO · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · FARXIGA · General - Therapies · LEQVIO · LINQ II · LifeVest · Micra · NUVISION ICE CATHETER · OPSUMIT · PRALUENT · PULSESELECT · Reveal LINQ · SelectSecure · TACTICATH · UPTRAVI · VERQUVO · VIEWMATE · Vascular Closure Device · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Cardiologists within 10 mi
547
Per 100K population
84.7
County median income
$111,951
Nearest hospital
DOYLESTOWN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sangrigoli is an electrophysiology & remote specialist, with above-average Medicare volume (top 30% in PA), with speaking/promotional industry engagement in the top 11% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sangrigoli experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Sangrigoli performed 663 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sangrigoli receive payments from pharmaceutical companies?
Yes. Dr. Sangrigoli received a total of $35,236 from 21 companies across 150 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sangrigoli's costs compare to other cardiologists in Doylestown?
Dr. Sangrigoli's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sangrigoli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Doylestown
Browse cardiologists in Doylestown ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology